$3.93
0.26% today
Nasdaq, Aug 12, 04:49 pm CET
ISIN
US64131A1051
Symbol
STIM

Neuronetics, Inc. Stock price

$3.92
+0.35 9.80% 1M
-0.01 0.25% 6M
+2.31 143.48% YTD
+3.18 426.17% 1Y
-0.55 12.30% 3Y
-0.88 18.33% 5Y
-23.86 85.89% 10Y
-23.86 85.89% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.21 5.08%

Key metrics

Basic
Market capitalization
$259.2m
Enterprise Value
$294.3m
Net debt
$35.1m
Cash
$20.2m
Shares outstanding
65.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.9 | 1.7
EV/Sales
3.3 | 1.9
EV/FCF
negative
P/B
7.3
Financial Health
Equity Ratio
19.7%
Return on Equity
-157.8%
ROCE
-36.8%
ROIC
-
Debt/Equity
1.6
Financials (TTM | estimate)
Revenue
$89.5m | $153.7m
EBITDA
$-40.7m | $-6.6m
EBIT
$-43.1m | $-15.8m
Net Income
$-48.5m | $-24.0m
Free Cash Flow
$-37.3m
Growth (TTM | estimate)
Revenue
22.2% | 105.2%
EBITDA
-59.9% | 76.7%
EBIT
-56.9% | 48.3%
Net Income
-76.1% | 45.2%
Free Cash Flow
-18.9%
Margin (TTM | estimate)
Gross
63.5%
EBITDA
-45.5% | -4.3%
EBIT
-48.2%
Net
-54.2% | -15.6%
Free Cash Flow
-41.7%
More
EPS
$-0.8
FCF per Share
$-0.6
Short interest
12.6%
Employees
716
Rev per Employee
$100.0k
Show more

Is Neuronetics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Neuronetics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Neuronetics, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Neuronetics, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Neuronetics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
89 89
22% 22%
100%
- Direct Costs 33 33
82% 82%
36%
57 57
3% 3%
64%
- Selling and Administrative Expenses 83 83
16% 16%
93%
- Research and Development Expense 8.04 8.04
11% 11%
9%
-41 -41
60% 60%
-46%
- Depreciation and Amortization 2.42 2.42
18% 18%
3%
EBIT (Operating Income) EBIT -43 -43
57% 57%
-48%
Net Profit -49 -49
76% 76%
-54%

In millions USD.

Don't miss a Thing! We will send you all news about Neuronetics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neuronetics, Inc. Stock News

Neutral
GlobeNewsWire
6 days ago
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to six new employees as described below. In accordance with NASDAQ Listing Ru...
Neutral
Seeking Alpha
7 days ago
Neuronetics, Inc. (NASDAQ:STIM ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Keith J. Sullivan - President, CEO & Director Steven E.
Neutral
GlobeNewsWire
8 days ago
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that Keith Sullivan, President and Chief Executive Officer, w...
More Neuronetics, Inc. News

Company Profile

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Head office United States
CEO Keith Sullivan
Employees 716
Founded 1998
Website neurostar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today